Publications by authors named "Eline Boon"

Claim this Profile
C
Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study.
Nan Ding, Renee Visserman, Sandra M E Geurts, Jolien Tol, Birgit E P J Vriens, Eline Boon

Breast· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor Discordance During the Treatment Course of Patients With Metastatic Breast Cancer: Results From the SONABRE Registry.
Karlijn E P E Hermans, Sandra M E Geurts, Franchette Van den Berkmortel, Jolien Tol, Joan B Heijns, Eline Boon

Clin Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle cramps and contractures: causes and treatment.
Jildou N Dijkstra, Eline Boon, Nick Kruijt, Esther Brusse, Sithara Ramdas

Pract Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer.
Erik J van Helden, Lindsay Angus, C Willemien Menke-van der Houven van Oordt, Daniëlle A M Heideman, Eline Boon

Mol Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results.
Suzanne C van Es, Bert van der Vegt, Frederike Bensch, Sophie Gerritse, Erik J van Helden, Eline Boon

Am J Surg Pathol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesion detection by [Zr]Zr-DFO-girentuximab and [F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
Sarah R Verhoeff, Suzanne C van Es, Eline Boon, Erik van Helden, Lindsay Angus

Eur J Nucl Med Mol Imaging· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Eline Boon, Miranda Bel, Wim van Boxtel, Winette T A van der Graaf, Robert J J van Es

Int J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
Eline Boon, Wim van Boxtel, Jan Buter, Robert J Baatenburg de Jong, Robert J J van Es

Head Neck· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma.
Wim van Boxtel, Eline Boon, Willem L J Weijs, Frank J A van den Hoogen, Uta E Flucke

Oral Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
Eline Boon, Winette T A van der Graaf, Hans Gelderblom, Margot E T Tesselaar, Robert J J van Es

Head Neck· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural differences between two types of basidiomycete septal pore caps.
Wally H Müller, Roy C Montijn, Bruno M Humbel, Adriaan C van Aelst, Eline J M C Boon

Microbiology (Reading)· July 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis